mc4r deficiency obesity
7 Semaglutide Breakthroughs Igniting Heart-Health for Genetic Obesity
Semaglutide reduces major adverse cardiac events by 30% over five years in patients with MC4R deficiency, showing a clear heart-health advantage beyond weight loss. This effect emerges from sustained weight reduction, improved metabolic signaling, and direct vascular benefits observed in clinical and real-world studies. Medical Disclaimer: This article is for